Cardiome Pharma Corp. to Hold Conference Call

Published: Sep 26, 2012

VANCOUVER, British Columbia, Sept. 26, 2012 (GLOBE NEWSWIRE) -- Cardiome Pharma Corp. (Nasdaq:CRME) (TSX:COM) today announced that a teleconference call and webcast will be held on Wednesday, September 26, 2012 at 9:00 am Eastern (6:00am Pacific) to discuss Merck's return of the global marketing and development rights for vernakalant to Cardiome.

Back to news